We hypothesized that DC vaccination would activate and expand glioma-specific T cells whose recall response to gamma chain survival cytokines and/or TH1-type cytokines, such as interleukin 2 (IL-2) and interferon gamma (IFN-γ), would be enhanced. Here, IL2 is linked to central nervous system cancer.